Maven Securities LTD
Broker-DealerPosition in SYRE — Spyre Therapeutics, Inc.
CIK 1633046
ST HELIER, Y9
Position in SYRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,551,200
New position
Shares Held
40,000
first reported quarter
Ownership
0.045%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#113
of 265 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Maven Securities LTD holds $27,509,646 across 11 Biotechnology names. SYRE ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
115,018 | $15,266,339 | |
| 2 | TECH |
BIO-TECHNE Corp
|
54,711 | $3,865,332 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
This page
|
40,000 | $3,551,200 | |
| 4 | OKYO |
OKYO Pharma Ltd
|
809,317 | $1,213,975 | |
| 5 | JBIO |
Jade Biosciences, Inc.
|
50,000 | $1,111,000 | |
| 6 | SION |
Sionna Therapeutics, Inc.
|
20,000 | $879,800 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
20,000 | $774,000 | |
| 8 | GRCE |
Grace Therapeutics, Inc.
|
200,000 | $454,000 |
All Filings in SYRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,551,200 | 40,000 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||